TCG Crossover GP II, LLC - Oct 10, 2025 SCHEDULE 13G Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
GLUE
Shares outstanding
61.5M shares
Disclosed Ownership
4.43M shares
Ownership
7.2%
Form type
SCHEDULE 13G
Date filed
10/17/2025, 04:29 PM
Date of event
Oct 10, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 3.6% 2.21M 0 2.21M /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 3.6% 2.21M 0 2.21M /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 3.6% 2.21M 0 2.21M /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 3.6% 2.21M 0 2.21M /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 7.2% 4.43M 0 4.43M /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu